United States, Food and Drug Administration -- Management
Resource Information
The concept United States, Food and Drug Administration -- Management represents the subject, aboutness, idea or notion of resources found in Biddle Law Library.
The Resource
United States, Food and Drug Administration -- Management
Resource Information
The concept United States, Food and Drug Administration -- Management represents the subject, aboutness, idea or notion of resources found in Biddle Law Library.
- Label
- United States, Food and Drug Administration -- Management
- Numeration
- Food and Drug Administration
- Subordinate unit
- Food and Drug Administration
41 Items that share the Concept United States, Food and Drug Administration -- Management
Context
Context of United States, Food and Drug Administration -- ManagementSubject of
- A consumer's perspective on medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, March 30, 1995
- Allegations of FDA abuses of authority : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, July 25, November 15, and December 5, 1995
- American lives still at risk : when will FDA's food protection plan be fully funded and implemented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 12, 2008
- Anthrax vaccine : safety and efficacy issues : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Committee on Government Reform, House of Representatives
- Changes in FDA structure
- Deficiencies in FDA's regulation of the marketing of unapproved new drugs : the case of E-Ferol : sixty-eighth report
- Delays in the FDA's food additive petition process and gras affirmation process : hearings before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 22 and 29, 1995
- Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001
- FDA Advisory Committee conflict of interest reform efforts in the 110th Congress
- FDA Modernization Act : implementation of the law : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999
- FDA Modernization Act : implementation of the law : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999
- FDA integrity issues : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on Visx Inc. document disclosure, July 31, 1996
- FDA management and enforcement : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, September 12, 1991
- FDA reform legislation : hearings before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on H.R. 3199, 3200, and 3201, May 1 and 2, 1996
- FDA resources
- FDA's regulation of food imports : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, first session, June 16, 1993
- Food and Drug Administration : Data To Measure the Timeliness of Reviews of Medical Device Applicants Are Limited.
- Food and Drug Administration : opportunities exist to better address management challenges : report to congressional requesters
- Food and Drug Administration Modernization Act of 1997 : conference report (to accompany S. 830)
- Food and Drug Administration Modernization and Accountability Act of 1997 : report together with additional and minority views (to accompany S. 830)
- Food and Drug Administration Performance and Accountability Act of 1995 : report together with additional views (to accompany S. 1477)
- Food and Drug Administration management concerns : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998
- How do we fix our ailing food safety system? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, March 11, 2009
- Implementation of the Food and Drug Administration Modernization Act of 1997 : hearing before the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, October 7, 1998
- Implementation of the Food and Drug Administration Modernization Act of 1997 : hearing before the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, October 7, 1998
- Legislative changes and administrative improvements should be considered for FDA to better protect the public from adulterated food products : report to the chairman, Subcommittee on Oversight and Investigations, House Committee on Energy and Commerce
- Medical devices : FDA should take steps to ensure that high-risk device types are approved through the most stringent premarket review process : report to congressional addressees
- Medical devices : reprocessing and reuse of devices labeled single-use : statement of Janet Heinrich, Associate Director, Health Financing and Public Health Issues, Health, Education, and Human Services Division, before the Committee on Health, Education, Labor, and Pensions, U.S. Senate
- Naked reverse : Secretary Sullivan's rescission of his delegation of investigative authority to the Inspector General : a staff report
- Pediatric Research Equity Act of 2003 : report together with additional views (to accompany S. 650)
- Pediatric drug research : substantial increase in studies of drugs for children, but some challenges remain : statement of Janet Heinrich, Director, Health Care--Public Health Issues, [before the] Committee on Health, Education, Labor and Pensions, U.S. Senate
- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives
- Prescription drugs : trends in FDA's oversight of direct-to-consumer advertising : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives
- Programs affecting safety and innovation in pediatric therapies : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 22, 2007
- Protecting the public health : examining FDA's initiatives and priorities : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session ... March 13, 2014
- Reauthorization of the Prescription User Fee Act and FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997
- Reauthorization of the Prescription User Fee Act and FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997
- Staff report on Sanofi's strategic use of third parties to influence the FDA
- The FDA food additive review process : backlog and failure to observe statutory deadline : fourth report
- The need for FDA regulatory reform to protect the health and safety of Americans : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 9, 1995
- Without reasonable assurance, financials and property management concerns at the Food and Drug Administration : a staff report
Embed (Experimental)
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.law.upenn.edu/resource/GaVj-VwkG8g/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.law.upenn.edu/resource/GaVj-VwkG8g/">United States, Food and Drug Administration -- Management</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.law.upenn.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.law.upenn.edu/">Biddle Law Library</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Concept United States, Food and Drug Administration -- Management
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.law.upenn.edu/resource/GaVj-VwkG8g/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.law.upenn.edu/resource/GaVj-VwkG8g/">United States, Food and Drug Administration -- Management</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.law.upenn.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.law.upenn.edu/">Biddle Law Library</a></span></span></span></span></div>
